What is the equity of Nicox this year?
Nicox has equity of 21.41 M EUR this year.
Nicox Equity 2024
Nicox Equity
21.41 M EUR
Ticker
ALCOX.PA
ISIN
FR0013018124
WKN
A143G8
In 2024, Nicox's equity was 21.41 M EUR, a -59.16% increase from the 52.43 M EUR equity in the previous year.
Nicox Aktienanalyse
What does Nicox do?
Nicox SA is a French pharmaceutical company specializing in the development and commercialization of innovative therapy systems for eye diseases. It was founded in 1996 as a spin-off of Nestlé's research activities in the field of ophthalmology. The company's business model is based on the development of drugs based on nitric oxide (NO), a gaseous molecule that plays an important role in regulating blood flow and inflammation processes in the human body. Nicox SA's technology allows for the targeted release of NO donors in specific areas of the eye to reduce disease-related inflammation and damage. This provides a promising alternative to conventional therapies for a range of eye diseases. Nicox SA is divided into three business areas: Ophthalmology, Diagnostics, and Contracts. In the Ophthalmology segment, the company focuses on the development of drugs for the treatment of glaucoma, dry eye, and other eye diseases. Important products in this area include Vyzulta, a combination of an NO donor and a glaucoma drug, as well as NCX 470, an NO donor for the treatment of glaucoma. In addition, the company is working on the development of NCX 4251, an NO donor for the treatment of blepharitis, an inflammation of the eyelids. In the Diagnostics segment, Nicox SA offers innovative diagnostic tests for ophthalmology based on tear fluid analysis. These tests enable ophthalmologists to diagnose and monitor certain eye diseases more quickly and accurately. Key products in this area include AdenoPlus, a rapid test for diagnosing adenovirus conjunctivitis, and ClearSight, a test for monitoring glaucoma patients. The Contracts segment offers customized clinical research services for customers in the pharmaceutical industry. This segment is an important part of Nicox SA's strategy to generate additional revenue and finance the development of new therapies. Overall, Nicox SA has a strong pipeline of new therapies and diagnostic tests that allow the company to consolidate its position as a leading provider of eye medications. The company works closely with its industry and academic research partners to develop and bring innovative therapies to the market. In summary, Nicox SA is an innovative and rapidly growing company focusing on the development and commercialization of therapies for eye diseases. The company has a strong pipeline of new products and services and collaborates closely with its partners to strengthen its position in the industry. Nicox ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Nicox's Equity
Nicox's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nicox's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Nicox's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Nicox's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Nicox’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Nicox stock
What was the equity of Nicox compared to the previous year?
The equity of Nicox has increased/decreased by -59.16% decreased compared to the previous year.
What impact does a high equity have on investors of Nicox?
A high equity is advantageous for investors of Nicox as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Nicox?
A low equity can be a risk for investors of Nicox, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Nicox affect the company?
An increase in equity of Nicox can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Nicox affect the company?
A reduction in equity of Nicox can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Nicox?
Some factors that can affect the equity of Nicox include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Nicox so important for investors?
The equity of Nicox is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Nicox take to change the equity?
To change equity, Nicox can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Nicox pay?
Over the past 12 months, Nicox paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nicox is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nicox?
The current dividend yield of Nicox is .
When does Nicox pay dividends?
Nicox pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nicox?
Nicox paid dividends every year for the past 0 years.
What is the dividend of Nicox?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nicox located?
Nicox is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nicox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nicox from 10/12/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/12/2024.
When did Nicox pay the last dividend?
The last dividend was paid out on 10/12/2024.
What was the dividend of Nicox in the year 2023?
In the year 2023, Nicox distributed 0 EUR as dividends.
In which currency does Nicox pay out the dividend?
The dividends of Nicox are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nicox stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nicox
Our stock analysis for Nicox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nicox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.